Establishment Labs Holdings Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 1,004

Employees

  • Stock Symbol
  • ESTA

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $69.21
  • (As of Friday Closing)

Establishment Labs Holdings General Information

Description

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Coyol Free Zone, B15
  • Alajuela
  • Costa Rica
+506 2434
Primary Industry
Therapeutic Devices
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • Coyol Free Zone, B15
  • Alajuela
  • Costa Rica
+506 2434

Establishment Labs Holdings Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Establishment Labs Holdings Stock Performance

As of 20-Nov-2026, Establishment Labs Holdings’s stock price is $69.21. Its current market cap is $2.06B with 29.8M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$69.21 $69.61 $53.16 - $97.59 $2.06B 29.8M 414K -$1.28

Establishment Labs Holdings Financials Summary

As of 30-Sep-2026, Establishment Labs Holdings has a trailing 12-month revenue of $264M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,104,904 2,308,274 1,484,774 804,976
Revenue 264,029 211,076 166,025 165,151
EBITDA (8,013) (22,715) (57,699) (59,327)
Net Income (38,454) (51,064) (84,596) (78,502)
Total Assets 358,876 357,167 346,831 268,641
Total Debt 269,529 264,467 225,294 192,224
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Establishment Labs Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Establishment Labs Holdings‘s full profile, request access.

Request a free trial

Establishment Labs Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic produc
Therapeutic Devices
Alajuela, Costa Rica
1,004 As of 2025

Princeton, NJ
 

Minneapolis, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Establishment Labs Holdings Competitors (7)

One of Establishment Labs Holdings’s 7 competitors is Integra LifeSciences Holdings, a Corporation company based in Princeton, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Integra LifeSciences Holdings Corporation Princeton, NJ
Medtronic Corporation Minneapolis, MN
Novo Nordisk Corporation Bagsvaerd, Denmark
Cutera Formerly VC-backed Brisbane, CA
Lumenis Private Equity-Backed Yokneam, Israel
You’re viewing 5 of 7 competitors. Get the full list »

Establishment Labs Holdings Patents

Establishment Labs Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026093796-A1 Scaffold sheet for promoting tissue formation Pending 30-Oct-2024
EP-4642385-A2 Minimally invasive implant procedure and system Pending 29-Dec-2022
US-20260026927-A1 Minimally invasive implant procedure and system Pending 29-Dec-2022
WO-2024141785-A2 Minimally invasive implant procedure and system Inactive 29-Dec-2022
WO-2024141785-A3 Minimally invasive implant procedure and system Inactive 29-Dec-2022 A61F2/12
To view Establishment Labs Holdings’s complete patent history, request access »

Establishment Labs Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Establishment Labs Holdings Investments & Acquisitions (3)

Establishment Labs Holdings’s most recent deal was a Corporate Asset Purchase with AFS Medical (Inventory, Customer Relationships And Contracts) for . The deal was made on 31-Jan-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AFS Medical (Inventory, Customer Relationships And Contracts) 31-Jan-2019 Corporate Asset Purchase Buildings and Property
Femiline (certain assets) 17-Nov-2017 Merger/Acquisition Distributors (Healthcare)
Magna Equities I (Certain Assets) 01-Nov-2015 Corporate Asset Purchase Buildings and Property
To view Establishment Labs Holdings’s complete investments and acquisitions history, request access »

Establishment Labs Holdings ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

36.53 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Establishment Labs Holdings’s complete esg history, request access »

Establishment Labs Holdings FAQs

  • When was Establishment Labs Holdings founded?

    Establishment Labs Holdings was founded in 2004.

  • Where is Establishment Labs Holdings headquartered?

    Establishment Labs Holdings is headquartered in Alajuela, Costa Rica.

  • What is the size of Establishment Labs Holdings?

    Establishment Labs Holdings has 1,004 total employees.

  • What industry is Establishment Labs Holdings in?

    Establishment Labs Holdings’s primary industry is Therapeutic Devices.

  • Is Establishment Labs Holdings a private or public company?

    Establishment Labs Holdings is a Public company.

  • What is Establishment Labs Holdings’s stock symbol?

    The ticker symbol for Establishment Labs Holdings is ESTA.

  • What is the current stock price of Establishment Labs Holdings?

    As of 20-Nov-2026 the stock price of Establishment Labs Holdings is $69.21.

  • What is the current market cap of Establishment Labs Holdings?

    The current market capitalization of Establishment Labs Holdings is $2.06B.

  • What is Establishment Labs Holdings’s current revenue?

    The trailing twelve month revenue for Establishment Labs Holdings is $264M.

  • Who are Establishment Labs Holdings’s competitors?

    Integra LifeSciences Holdings, Medtronic, Novo Nordisk, Cutera, and Lumenis are some of the 7 competitors of Establishment Labs Holdings.

  • What is Establishment Labs Holdings’s annual earnings per share (EPS)?

    Establishment Labs Holdings’s EPS for 12 months was -$1.28.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process